Literature DB >> 18023922

Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece.

I Wybo1, L Blommaert, T De Beer, O Soetens, J De Regt, P Lacor, D Piérard, S Lauwers.   

Abstract

Multidrug-resistant (MDR) Acinetobacter baumannii are emerging as important nosocomial pathogens. These organisms have a capacity for long-term survival in the hospital environment. The purpose of this study was to describe the course and control of an outbreak with MDR A. baumannii in a Belgian university hospital after transfer of two trauma patients from Greece. Wounds in both patients were colonised with MDR A. baumannii. Over an 11 month period from September 2004 to July 2005, carbapenem-non-susceptible A. baumannii (producing carbapenem-hydrolysing oxacillinase OXA-58) were isolated from 28 patients, despite early implementation of contact precautions. MDR A. baumannii was detected in routine clinical diagnostic samples from 26 patients and in screening specimens from an additional two patients. Twenty patients (71.4%) were colonised or infected during their stay in intensive care. Twenty-four (85.7%) respiratory samples were positive for MDR A. baumannii. Careful review of all procedures related to the respiratory tract did not identify a common route of transmission. Outbreak control required multiple interventions, including contact isolation of colonised and infected patients, monitoring the practice of personnel, screening of asymptomatic patients, use of isolation rooms and enhanced environmental disinfection. Introduction of single-use ventilator circuits was considered but the outbreak was controlled before implementation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023922     DOI: 10.1016/j.jhin.2007.09.012

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  13 in total

Review 1.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

2.  Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program.

Authors:  Won Suk Choi; Su Hyun Kim; Eun Gyong Jeon; Myeung Hee Son; Young Kyung Yoon; Jung-Yeon Kim; Mi Jeong Kim; Jang Wook Sohn; Min Ja Kim; Dae Won Park
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

3.  Molecular Detection of Adefg Efflux Pump Genes and their Contribution to Antibiotic Resistance in Acinetobacter baumannii Clinical Isolates.

Authors:  Rasoul Kaviani; Iman Pouladi; Mohammad Niakan; Reza Mirnejad
Journal:  Rep Biochem Mol Biol       Date:  2020-01

4.  Acinetobacter baumannii producing OXA-23 detected in the Czech Republic.

Authors:  Marketa Senkyrikova; Vendula Husickova; Magdalena Chroma; Pavel Sauer; Jan Bardon; Milan Kolar
Journal:  Springerplus       Date:  2013-07-02

5.  Multi-locus sequence typing (MLST) of non-fermentative Gram-negative bacilli isolated from bloodstream infections in southern Poland.

Authors:  Agnieszka Chmielarczyk; Monika Pobiega; Dorota Romaniszyn; Jadwiga Wójkowska-Mach
Journal:  Folia Microbiol (Praha)       Date:  2017-09-22       Impact factor: 2.099

Review 6.  Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens?

Authors:  Caroline Landelle; Leonardo Pagani; Stephan Harbarth
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

Review 7.  Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for Institutes.

Authors:  Chang-Hua Chen; Li-Chen Lin; Yu-Jun Chang; Yu-Min Chen; Chin-Yen Chang; Chieh-Chen Huang
Journal:  Int J Environ Res Public Health       Date:  2015-07-30       Impact factor: 3.390

Review 8.  Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections.

Authors:  Uh Jin Kim; Hee Kyung Kim; Joon Hwan An; Soo Kyung Cho; Kyung-Hwa Park; Hee-Chang Jang
Journal:  Chonnam Med J       Date:  2014-08-20

9.  Parenteral colistin for the treatment of severe infections: a single center experience.

Authors:  Marcos Toshyiuki Tanita; Claudia Maria Dantas de Maio Carrilho; Joseani Pascual Garcia; Josiane Festti; Lucienne Tibery Queiroz Cardoso; Cintia Magalhães Carvalho Grion
Journal:  Rev Bras Ter Intensiva       Date:  2013 Oct-Dec

10.  Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center.

Authors:  Daniel De Vos; Jean-Paul Pirnay; Florence Bilocq; Serge Jennes; Gilbert Verbeken; Thomas Rose; Elkana Keersebilck; Petra Bosmans; Thierry Pieters; Mony Hing; Walter Heuninckx; Frank De Pauw; Patrick Soentjens; Maia Merabishvili; Pieter Deschaght; Mario Vaneechoutte; Pierre Bogaerts; Youri Glupczynski; Bruno Pot; Tanny J van der Reijden; Lenie Dijkshoorn
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.